Meline David W

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 39% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Meline David W's trades of Pacific Biosciences of California Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Moderna Inc (MRNA)
Transaction date
Sale
Price
453.56
Quantity 34,058 -46.8%
Value US$578,172
US Moderna Inc (MRNA)
Transaction date
Sale
Price
247.92
Quantity 48,411 +16.4%
Value US$1,531,849
US Moderna Inc (MRNA)
Transaction date
Sale
Price
158.89
Quantity 619 -20.6%
Value US$98,354
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-06 2024-03-06
B Purchase
54,570 +39.9%
141.92
US$31,793 		54,570 +39.9% 141.92 US$31,793
2022-08-11 2022-08-10
US Moderna Inc (MRNA)
S Sale
34,058 -46.8%
453.56
US$578,172 		34,058 -46.8% 453.56 US$578,172
2022-05-11 2022-05-10
US Moderna Inc (MRNA)
S Sale
48,411 +16.4%
247.92
US$1,531,849 		48,411 +16.4% 247.92 US$1,531,849
2022-02-11 2022-02-10
US Moderna Inc (MRNA)
S Sale
619 -20.6%
158.89
US$98,354 		619 -20.6% 158.89 US$98,354